Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, India. The company has a legacy of over 70 years in the healthcare industry and is engaged in discovering, developing, manufacturing, and marketing a broad range of healthcare therapies. Zydus specializes in active pharmaceutical ingredients (APIs), human formulations, animal health, and wellness products. Their product portfolio includes notable brands such as Lipaglyn (Saroglitazar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar), and Bryxta (Bevacizumab biosimilar). The company is committed to innovation and has a significant global presence with operations in the USA, Europe, and emerging markets.